Showing results (2351-2360 of 10,003) with videos related to
Sort By:
Pageof 1,001
Leukemia & Lymphoma|May 21, 2025
Carfilzomib in combination with R-CHOP for initial treatment of patients with non-germinal center diffuse large B-cell lymphoma: a multicenter, single arm, phase 1/2 studyBrian T Hill, Pallawi Torka, Francisco Hernandez-Ilizaliturri, et al.Leukemia & Lymphoma|May 23, 2025
Toxicity, progression-free survival, and quality of life of patients treated with zanubrutinib versus ibrutinib: a Q-TWiST analysis from the ALPINE study in relapsed or refractory chronic lymphocytic leukemiaVincent Lévy, Tushar Srivastava, Raju Gautam, et al.Leukemia & Lymphoma|June 2, 2025
Recent advances in monoclonal antibody development for treatment of B-cell acute lymphoblastic leukemiaHamideh Kamalloo, Mahnaz Fathi, Sobhan Bavandi, et al.Leukemia & Lymphoma|July 21, 2025
BCMA-targeting BiTE molecule AMG 420 in relapsed or refractory multiple myeloma: a phase 1b open-label expansion studyCesar Rodriguez, Tulio Rodriguez, Alain Kentos, et al.Leukemia & Lymphoma|May 8, 2025
Differences in time to treatment and impact on overall survival in adolescents and young adults with Hodgkin lymphomaCarlos A Cruz, Elizabeth R Rodriguez, Maanvi Thawani, et al.Leukemia & Lymphoma|April 25, 2025
Clinicopathological and global methylation profiling of acute myeloid leukemia with mutations in NPM1 and clonal hematopoiesis-related genesMostafa Elhodaky, Drew Duckett, Lucas Santana-Santos, et al.Leukemia & Lymphoma|October 27, 2025
Prognostic relevance of the neutrophil/lymphocyte ratio in diffuse large B-cell lymphoma: a systematic review and meta-analysis and dose-response evidenceRafael Pichardo-Rodriguez, José M Vela-Ruiz, Luis Villela, et al.Leukemia & Lymphoma|October 27, 2025
Germline predisposition to acute myeloid leukemia in polish patientsAneta Bąk, Magdalena Pasińska, Anna Jaśkowiec, et al.Leukemia & Lymphoma|October 10, 2025
Clinical and biological predictors of treatment-free remission in CMLEdwina Sutton, Naranie Shanmuganathan, David RossLeukemia & Lymphoma|October 8, 2025
Soluble BCMA as a biomarker reflecting tumor volume and treatment response in Waldenström macroglobulinemiaMitsuaki Oura, Daisuke Ikeda, Shuichi Aikawa, et al.Pageof 1,001